A Pulitzer Prize-winning weekly covering West Marin, including the towns of Point Reyes Station, Inverness, Bolinas, Stinson Beach, Marshall, Nicasio, Lagunitas, Woodacre, San Geronimo, Forest Knolls, ...
A Pulitzer Prize-winning weekly covering West Marin, including the towns of Point Reyes Station, Inverness, Bolinas, Stinson Beach, Marshall, Nicasio, Lagunitas, Woodacre, San Geronimo, Forest Knolls, ...
Oppenheimer analyst Matthew Biegler maintained a Buy rating on Olema Pharmaceuticals (OLMA – Research Report) today and set a price target of ...
It looks like Eli Lilly’s oral selective estrogen receptor degrader (SERD) imlunestrant may need some extra help to reach a ...
H.C. Wainwright analyst Emily Bodnar maintained a Buy rating on Olema Pharmaceuticals (OLMA – Research Report) today and set a price target of ...
An experimental drug stops advanced breast cancer from progressing in some people with tumors that have grown resistant to ...
Imlunestrant, an investigational next-generation selective estrogen receptor degrader (SERD), improved progression-free survival in patients with endocrine therapy-pretreated, ER-positive, ...
Olema presented Phase 1b/2 trial data for palazestrant combined with Novartis's Kisqali in ER-positive, HER2-negative breast ...
Novartis NVS announced positive top-line results from a late-stage study on Fabhalta (iptacopan) in adult patients with ...
Olema Pharmaceuticals shares rose 5.3% in premarket trading Monday after its investigational new drug application for OP-3136 was approved by the Food and Drug Administration. Shares were trading ...
"We are very pleased to have received notification from the FDA that OP-3136 may proceed into the clinic,” said David C. Myles, Ph.D., Chief Discovery and Non-Clinical Development Officer of Olema ...
Wednesday, December 11 Santa Claus at Buttermilk Baby Buttermilk Baby, 600 North Shepherd, invites folks to a special visit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback